Glenn Faass and Mauricio Zagarra discuss Norton Rose Group's presence in Colombia with La Republica.
One of the five largest law firms in the world, Norton Rose Group, has entered Colombia thanks to its merger with the Canadian company Macleod Dixon. In January this year it opened its first offices in Latin America, bearing in mind that Macleod Dixon was operating here since September 2010.
In the LR’s interview with Glenn Faass, Managing Partner of Macleod Dixon in Colombia, he explained the sectors they would be focusing on, the type of advice they will be offering, their expectations and future projects, among others.
Which are the sectors you are most concentrating on?
We are strong in six sectors – energy, petroleum, mining, transport and infrastructure, IT and pharmaceuticals.
What kind of legal advice will you provide?
We lend our services mainly to companies; assessment they may need in tax, labor, corporate, litigation matters and in mergers and acquisitions.
What was your turnover in 2011?
Global income for 2011 was in excess of USD 1.3 billion.
What are your expectations with this merger?
We have a very strong practice in natural resources and are hoping for a significant increase in our financial institutions, transport and infrastructure business.
Do you plan to move into other countries in Latin America?
We are continuously evaluating other countries, but we have nothing specific planned at this moment for Latin America.
Mauricio Zagarra, Partner of Norton Rose in Colombia, commented on certain important aspects regarding clients and the number of offices world-wide, among others.
How many offices do you have world-wide following the merger?
Thanks to the merger we now have 43 offices in 26 countries with over 6,000 employees and more than 2,900 lawyers.
Who are your main clients?
We participated as counsel in the transaction of the sale of the assets of British Petroleum (BP), representing Ecopetrol and Talismán; Pacific Rubiales and Gran Colombia Gold are also clients of ours in the mining and oil sectors.
Zagarra also noted that “through the merger we hope to develop the pharmaceutical and financial sectors.”